Clinch Memorial Hospital | |
1050 Valdosta Highway, Homerville, Georgia 31634 | |
(912) 487-5211 | |
Not Available |
Name | Clinch Memorial Hospital |
---|---|
Type | Critical Access Hospital |
Location | 1050 Valdosta Highway, Homerville, Georgia |
Ownership | Government - Hospital District or Authority |
Emergency Services | Yes |
Medicare ID (CCN) | 111308 |
NPI Number | 1861478851 |
Organization Name | CLINCH COUNTY HOSPITAL AUTHORITY |
Address | 1050 Valdosta Hwy, Homerville, GA 31634 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 912-487-5211 |
News Archive
Approximately 5,000 families (pregnant women, fathers and newborns) are being asked to take part in a new study called Étude 3-D (Découvrir, Développer, Devenir) that is aimed at understanding the effects of perinatal events on child development. The study is directed by Dr. William Fraser, Associate Director of Clinical Research at the CHU Sainte-Justine and professor of Medicine at the University of Montreal.
Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
A team of investigators has discovered that the underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma (ccRCC), according to a recent study published in Proceedings of the National Academy of Sciences.
In the past, when government leaders, policymakers and scholars have turned their attention to peace and security issues, the talk invariably has focused on war, arms control or anti-terrorism strategies. But Julian Palmore believes it's time to expand the scope of the conversation.
› Verified 2 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Approximately 5,000 families (pregnant women, fathers and newborns) are being asked to take part in a new study called Étude 3-D (Découvrir, Développer, Devenir) that is aimed at understanding the effects of perinatal events on child development. The study is directed by Dr. William Fraser, Associate Director of Clinical Research at the CHU Sainte-Justine and professor of Medicine at the University of Montreal.
Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
A team of investigators has discovered that the underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma (ccRCC), according to a recent study published in Proceedings of the National Academy of Sciences.
In the past, when government leaders, policymakers and scholars have turned their attention to peace and security issues, the talk invariably has focused on war, arms control or anti-terrorism strategies. But Julian Palmore believes it's time to expand the scope of the conversation.
› Verified 2 days ago
Clinch Memorial Hospital Critical Access Hospital Location: 1050 Valdosta Highway, Homerville, Georgia 31634 Phone: (912) 487-5211 |